FDA (Drugs) recall action 65154
The FDA (Drugs) publishes a recall like this one as 20 separate product records. They share a firm, a date and a cause; this page is all of them in one place, so the scale of the action is visible rather than spread across 20 pages.
cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.
The agency’s own wording, quoted from the enforcement report.
The unit total adds up the quantities the agency stated for each product. Where a product record gave no figure, or gave a weight rather than a count, it contributes nothing — so the real total is at least this, never less.
Lloyd Inc. of Iowa is recalling Levothroid (levothyroxine sodium) tablets due to cGMP deviations and insufficient stability data.
Lloyd Inc. of Iowa is recalling bulk Thyro-Tab 0.088 mg tablets due to cGMP deviations and stability failures. The product was repackaged by Forest Laboratories and distributed nationwide.
Lloyd Inc. of Iowa is recalling 4,440 bottles of Levothroid 50 mcg tablets due to cGMP deviations and stability failures in previous lots.
Lloyd Inc. of Iowa is recalling bulk Thyro-Tab tablets due to cGMP deviations and stability failures. The product was repackaged and distributed nationwide.
Lloyd Inc. of Iowa is recalling Levothroid (levothyroxine sodium) tablets due to cGMP deviations and insufficient stability data.
Lloyd Inc. of Iowa is recalling 9.5 million Thyro-Tab tablets due to cGMP deviations and insufficient stability data.
Lloyd Inc. of Iowa is recalling specific lots of Levothroid tablets due to stability failures and insufficient data to rule out other affected lots.
Lloyd Inc. of Iowa is recalling bulk Thyro-Tab tablets due to cGMP deviations and stability failures. The product was distributed to Forest Laboratories for repackaging.
Lloyd Inc. of Iowa is recalling Levothroid (levothyroxine sodium) tablets due to cGMP deviations and insufficient stability data.
Lloyd Inc. of Iowa is recalling Levothroid tablets due to cGMP deviations and insufficient stability data. The recall affects 12,156 bottles distributed nationwide and to Puerto Rico.
Lloyd Inc. of Iowa is recalling Levothroid (levothyroxine sodium) tablets due to cGMP deviations and stability failures. The recall covers specific lots distributed nationwide and to Puerto Rico.
Lloyd Inc. of Iowa is recalling Levothroid tablets due to cGMP deviations and insufficient stability data. The recall covers 142,103 bottles distributed nationwide and to Puerto Rico.
Lloyd Inc. of Iowa is recalling bulk Thyro-Tab 0.125 mg tablets due to cGMP deviations and insufficient stability data.
Lloyd Inc. of Iowa is recalling 7.6 million Thyro-Tab tablets due to cGMP deviations and stability failures. The product was distributed nationwide and to Puerto Rico.
Lloyd Inc. of Iowa is recalling Levothroid (levothyroxine sodium) tablets due to cGMP deviations and insufficient stability data.
Lloyd Inc. of Iowa is recalling bulk Thyro-Tab tablets due to cGMP deviations and stability failures. The product was repackaged by Forest Laboratories and distributed nationwide.
Lloyd Inc. of Iowa is recalling bulk Thyro-Tab 0.175 mg tablets due to cGMP deviations and stability failures. The product was distributed to Forest Laboratories for repackaging.
Lloyd Inc. of Iowa is recalling Levothroid tablets due to cGMP deviations and stability failures in previous lots.
Lloyd Inc. of Iowa is recalling 5.7 million Thyro-Tab tablets because stability failures in previous lots make it impossible to verify the quality of the current lots.
Lloyd Inc. of Iowa is recalling 3.8 million Thyro-Tab tablets due to cGMP deviations and insufficient stability data.